FAP-directed CAR-T cells have been developed to target CAFs in several solid tumors, including mesothelioma, lung cancer, and pancreatic cancer, demonstrating antitumor activity in preclinical models [36,37,38]. Here, FAP is linked to pancreatic neoplasm.